An Immunohistochemical Investigation of the Expression of Somatostatin Receptor Subtypes – Should Therapeutic Trials be Performed to Determine the Efficacy of Somatostatin Analogs in Treating Advanced Thyroid Malignances?-Reference-Cited by-同舟云学术

An Immunohistochemical Investigation of the Expression of Somatostatin Receptor Subtypes – Should Therapeutic Trials be Performed to Determine the Efficacy of Somatostatin Analogs in Treating Advanced Thyroid Malignances?

Published:2015-04-21 Issue:06 Volume:123 Page:342-346
ISSN:0947-7349
Container-title:Experimental and Clinical Endocrinology & Diabetes
language:en
Short-container-title:Exp Clin Endocrinol Diabetes

Author:

Pisarek H.¹,Pawlikowski M.²,Marchlewska M.³,Minias R.⁴,Winczyk K.¹

Affiliation:

1. Department of Neuroendocrinology, Chair of Laboratory Medicine, Medical University of Lodz, Poland

2. Department of Immunoendocrinology, Chair of Endocrinology, Medical University of Lodz, Poland

3. Department of General and Endocrinological Surgery, Copernicus Memorial Hospital, Lodz, Poland

4. Department of Pathomorphology and Clinical Cytopathology, Interfaculty Chair of Pathomorphology, Medical University of Lodz, Poland

Publisher

Georg Thieme Verlag KG

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0035-1548825.pdf

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide Receptor Radionuclide Therapy in Thyroid Cancer;Frontiers in Endocrinology;2022-05-30

2. Somatostatin receptors: localization and imagining methods (review);Russian Journal of Biotherapy;2022-04-12

3. Comparative distribution of somatostatin and somatostatin receptors in PTU-induced hypothyroidism;Endocrine;2020-04-25

4. Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models;PLOS ONE;2019-02-26

5. Characterization of somatostatin receptors (SSTRs) expression and antiproliferative effect of somatostatin analogues in aggressive thyroid cancers;Surgery;2019-01